4 completed, 1 withdrawn. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Withdrawn 1 |
| Phase 1 | 2 | Completed 2 |
Follow Beyond Air Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial) 150 ppm Nitric Oxide delivered through LungFit Delivery System, 80 ppm Nitric Oxide delivered through LungFit Delivery System - COVID-19, SARS-CoV 2 | Phase 2 | Withdrawn | Beyond Air Inc. | 2020-07-15 | 2021-01-22 | |
| Evaluation of Two Doses of Nitric Oxide (NO) Given Intermittently Via Inhalation to Subjects With Bronchiolitis Nitric Oxide, Standard Supportive treatment - Bronchiolitis Acute | Phase 2 | Completed | Beyond Air Inc. | 95 | 2019-11-06 | 2020-05-12 |
| Inhaled Nitric Oxide for Patients With MABSC Nitric Oxide - Mycobacterium Abscessus Infection | Phase 2 | Completed | Beyond Air Inc. | 9 | 2017-07-24 | 2019-07-09 |
| Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis Nitric oxide - Cystic Fibrosis | Phase 1 / Phase 2 | Completed | Beyond Air Inc. | 9 | 2013-12-01 | 2016-06-03 |
| Evaluation of the Safety and Tolerability of Nitric Oxide (NO) Via Inhalation to Subjects With Bronchiolitis Nitric Oxide, Placebo - Bronchiolitis | Phase 1 / Phase 2 | Completed | Beyond Air Inc. | 43 | 2013-01-01 | 2016-05-04 |
Respiratory Aspiration (2) · Bronchiolitis (1) · COVID-19 (1) · Coronavirus Infections (1) · Cystic Fibrosis (1) · Mycobacterium Infections, Nontuberculous (1) · Pneumonia, Viral (1) · Respiration Disorders (1)
Nitric Oxide (4)
Israel (4)
Asher Tal, M.D (2) · Asher Tal, MD (1) · Aviv Goldbart (1) · Hannah Blau, M.D (1)